| [1] Bilchik AJ,Hoon DS,Saha S,et al. Prognostic impact of micrometastases in colon cancer:interim results of a prospective multicenter trial[J]. Ann Surg,2007,246(4): 568-575.[2] 夏一芳,潘继红,常晓天. DNA拷贝数变化与肿瘤[J]. 国际肿瘤学杂志,2012,39(008):563-566.[3] Chen Z,Liu Z,Deng X,et al. Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer[J]. Dis Colon Rectum,2012,55(6):677-685.[4] Liang JW,Shi ZZ,Zhang TT,et al. Analysis of genomic aberrations associated with the clinicopathological parameters of rectal cancer by arraybased comparative genomic hybridization [J]. Oncol Rep,2013,29(5):1827-1834.[5] Sawada T,Yamamoto E,Suzuki H,et al. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization[J]. Genes,Chromosomes Cancer,2013,52(2):140-149.[6] Badagnani I,Chan W,Castro RA,et al. Functional analysis of genetic variants in the human concentrative nucleoside transporter 3(CNT3;SLC28A3)[J]. Pharmacogenomics J, 2005,5(3):157-165.[7] Perez-Torras S,Vidal-Pla A,Cano-Soldado P,et al. Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner [J]. Cell Death Dis,2013,4:e648.[8] Su F,Li H,Yan C,et al. Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells[J]. J Cancer Res Clin Oncol,2009,135(12): 1655-1663.[9] Shan J,Mahfoudh W,Dsouza SP,et al. Genome-wide association studies (GWAS) breast cancer susceptibility loci in Arabs:susceptibility and prognostic implications in Tunisians [J]. Breast Cancer Res Treat,2012,135(3):715-724.[10] Huijts P,Vreeswijk M,Kroeze-Jansema K,et al. Clinical correlates of low-risk variants in FGFR2,TNRC9,MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases[J]. Breast Cancer Res,2007,9(6):R78.[11] Grady WM,Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis[J]. Gastroenterology,2008, 135(4):1079-1099.[12] Rajagopalan H,Lengauer C. Aneuploidy and cancer[J]. Nature,2004,432(7015):338-341.[13] Feenstra M,Veltkamp M,Kuik JV,et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas[J]. Tissue Antigens,1999, 54(3):235-245.[14] Miao L,Zhu S,Wang Y,et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition [J]. Med Oncol,2013,30(3):1-9.[15] Koh M,Woo Y,Valiathan RR,et al. Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition[J]. Int J Cancer, 2015,136(6):508-520.[16] Yang SH,Baek HA,Lee HJ,et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas[J]. Oncol Rep,2010,24(2):311-319.[17] Maurer G,Tarkowski B,Baccarini M. Raf kinases in cancer-roles and therapeutic opportunities[J]. Oncogene,2011, 30(32):3477-3488.[18] Kajanne R,Miettinen P,Mehlem A,et al. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways[J]. J Cellular Physiol,2007,212(2): 489-497.[19] Verma N,Keinan O,Selitrennik M,et al. PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition[J]. Nat Commun,2015,6:6064.[20] Inoue H,Miyazaki Y,Kikuchi K,et al. Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity[J]. Tumor Biol,2012,33(1):183-194.[21] Zhang F,Zhang X,Li M,et al. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis[J]. Cancer Res,2010,70(22):9360-9370.[22] Hardy KM,Booth BW,Hendrix MJ,et al. ErbB/EGF signaling and EMT in mammary development and breast cancer[J]. J Mammary Gland Biol Neoplasia,2010,15(2): 191-199.[23] Kim HD,Meyer AS,Wagner JP,et al. Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts[J]. Mol & Cell Proteom, 2011,10(11):M111. 008433.[24] Rovenska E. Importance of lymphangiogenesis and ultrastructure of lymphatic capillaries in metastasis of malignant melanoma[J]. Vnitr Lek,2014,60(7/8):582-585.[25] Bracher A,Cardona AS,Tauber S,et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis[J]. J Invest Dermatol,2013, 133(1):230-238.[26] Chung HW,Kong HY,Lim JB. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer[J]. World J Gastroenterol,2015,21(7):2080-2088.[27] Sen R,Baltimore D.Multiple nuclear factors interact with theimmunoglobulin enhancer sequences[J]. Cell,1986,46(5): 705-716.[28] Grimm S,Baeuerle PA. The inducible transcription factor NF-kappa B:structure-function relationship of its protein subunits [J]. Biochemical J,1993,290(Sup2):297.[29] Arisawa T,Tahara T,Shiroeda H,et al. Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer[J]. Oncol Rep,2013,30(6):3013-3019. |
